NPPB and chronic lung disease: The next worst outcome, which was similar, was in Phenogroup4, which had the highest prevalence of ischemic etiology, smoking and chronic lung disease, the most symptoms, as well as highest NT-proBNP and troponin levels (Woolley et al., 2021[131]).